ARCHIVES

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

November 3, 2006

In Brief: Ross McIntyre To Retire As Center Director; Lasker Awards Honors O’Neill, Three Scientsts

October 4, 1991

NIH Recovery Act Announcements

March 27, 2009

Politics, Short Tempers, Grievances Dominate NIH Panel On Unconventional Medical Practices

September 25, 1992

Henschke Responds To Questions from The New York Times

April 29, 2011